- Associated Press - Thursday, June 13, 2013

WASHINGTON (AP) — The Supreme Court says companies cannot patent human genes, a decision that could profoundly affect the medical and biotechnology industries.

In a unanimous decision, the court struck down patents held by Myriad Genetics Inc. on two genes linked to increased risk of breast and ovarian cancer.

Opponents say patent protection shouldn’t be given to something that can be found inside the human body.

But lower courts approved, saying Myriad’s genes could be patented because the DNA it isolated and took from the body has a “markedly different chemical structure” from DNA found naturally within the body.

Justice Clarence Thomas wrote that the DNA is a product of nature and not eligible for a patent merely because it has been isolated.



Sign up for Daily Newsletters

Copyright © 2019 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide